KBio uses plants as biofoundries to produce therapeutics and bioactive compounds on a large scale. It leverages an efficient and sustainable process to produce high-quality proteins derived from plants.

KBio

Cloudflare Hosting

Gravity Forms

Chief Operating Officer

Barry Bratcher

Principal Scientist/Director Drug Discovery & Development

Elena Alessandra Federzoni

Director Analytical Services

Krystal Hamorsky

Principal Scientist / Director

Kurt Wong

Principal Scientist, Process Development and Manufacturing

Dmitry Serbzhinskiy

Engineering

Jason Morris

Principal Scientist

Jintang Du

Josh Morton

Kelsi Swope

Lauren Moore (Bennett)

Stefano Caselli

Sean Stevens

Patrick Doyle

Chief Executive Officer

Kentucky Companies (Top 10K)

Private Kentucky Companies (Top 10K)

Owensboro Companies

KBio aims to create a new generation of biologics using its plant-based platform.

Owensboro

Kentucky

United States

North America

KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study

KBio Appoints Sean Stevens, Ph.D. as Chief Scientific Officer

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 30, 2024 2:16 AM	83be1fd6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 30, 2024 2:16 AM	9189cbab
crunchbase trigger	general	Nov 27, 2024 12:50 PM	e4ffaf29
crunchbase profile	general	Nov 28, 2024 10:05 AM	92ab6ffc
li profile	general
translate crunchbase fundingrounds	general	Nov 28, 2024 10:19 AM	29c60775
peers	general	Oct 30, 2024 2:16 AM	5552f275
news basic	general	Oct 30, 2024 2:16 AM	551df881
bundesanzeiger	filings
financials download nd	financials
private financials	financials

KBIO

COM:KBIO

KBio